See more : Full Truck Alliance Co. Ltd. (YMM) Income Statement Analysis – Financial Results
Complete financial analysis of U.S. Physical Therapy, Inc. (USPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U.S. Physical Therapy, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Monroe Capital Corporation (MRCC) Income Statement Analysis – Financial Results
- Byggmax Group AB (publ) (BMAX.ST) Income Statement Analysis – Financial Results
- Beijing Beimo High-tech Frictional Material Co.,Ltd (002985.SZ) Income Statement Analysis – Financial Results
- Montea Comm. VA (0LBY.L) Income Statement Analysis – Financial Results
- JBM (Healthcare) Limited (2161.HK) Income Statement Analysis – Financial Results
U.S. Physical Therapy, Inc. (USPH)
About U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 604.80M | 553.14M | 495.02M | 422.97M | 481.97M | 453.91M | 414.05M | 356.55M | 331.30M | 305.07M | 264.06M | 252.09M | 237.01M | 211.23M | 201.41M | 187.69M | 151.69M | 135.19M | 132.12M | 118.31M | 105.57M | 94.74M | 80.95M | 63.22M | 49.94M | 44.00M | 38.80M | 32.20M | 24.90M | 17.20M | 8.40M | 2.40M | 600.00K |
| Cost of Revenue | 492.82M | 441.12M | 377.84M | 328.52M | 369.50M | 352.25M | 323.43M | 274.53M | 252.94M | 228.91M | 199.36M | 189.50M | 172.51M | 151.82M | 146.24M | 140.08M | 114.33M | 99.35M | 96.21M | 85.28M | 74.60M | 64.53M | 54.88M | 42.90M | 34.09M | 30.80M | 27.30M | 22.10M | 17.40M | 13.20M | 6.20M | 1.70M | 500.00K |
| Gross Profit | 111.99M | 112.02M | 117.18M | 94.45M | 112.47M | 101.66M | 90.62M | 82.01M | 78.36M | 76.17M | 64.70M | 62.59M | 64.49M | 59.42M | 55.17M | 47.60M | 37.36M | 35.84M | 35.91M | 33.03M | 30.96M | 30.21M | 26.07M | 20.32M | 15.84M | 13.20M | 11.50M | 10.10M | 7.50M | 4.00M | 2.20M | 700.00K | 100.00K |
| Gross Profit Ratio | 18.52% | 20.25% | 23.67% | 22.33% | 23.34% | 22.40% | 21.89% | 23.00% | 23.65% | 24.97% | 24.50% | 24.83% | 27.21% | 28.13% | 27.39% | 25.36% | 24.63% | 26.51% | 27.18% | 27.92% | 29.33% | 31.89% | 32.20% | 32.14% | 31.73% | 30.00% | 29.64% | 31.37% | 30.12% | 23.26% | 26.19% | 29.17% | 16.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 51.95M | 46.11M | 46.53M | 42.04M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 24.78M | 22.99M | 23.40M | 23.73M | 17.33M | 17.25M | 16.43M | 16.80M | 13.97M | 11.33M | 9.12M | 7.61M | 6.49M | 5.60M | 4.80M | 4.80M | 4.20M | 4.50M | 3.50M | 1.70M | 400.00K |
| Other Expenses | 0.00 | 859.00K | -4.60M | -13.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.79M | 3.24M | 3.35M | 0.00 | 0.00 | 0.00 | 604.00K | 238.00K | 0.00 | 0.00 | 0.00 | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| Operating Expenses | 42.43M | 46.11M | 41.94M | 28.54M | 45.05M | 41.35M | 35.89M | 32.48M | 31.07M | 30.40M | 25.93M | 24.78M | 28.56M | 26.23M | 26.74M | 23.73M | 17.33M | 17.25M | 17.03M | 17.04M | 13.97M | 11.33M | 9.12M | 9.94M | 8.58M | 7.70M | 6.70M | 6.50M | 5.90M | 5.80M | 4.10M | 1.90M | 400.00K |
| Cost & Expenses | 535.25M | 487.23M | 419.78M | 357.06M | 414.54M | 393.60M | 359.32M | 307.01M | 284.01M | 259.31M | 225.29M | 214.29M | 201.08M | 178.04M | 172.98M | 163.81M | 131.65M | 116.60M | 113.24M | 102.32M | 88.57M | 75.87M | 64.00M | 52.84M | 42.67M | 38.50M | 34.00M | 28.60M | 23.30M | 19.00M | 10.30M | 3.60M | 900.00K |
| Interest Income | 3.77M | 859.00K | 199.00K | 142.00K | 46.00K | 93.00K | 88.00K | 93.00K | 81.00K | 18.00K | 7.00K | 6.00K | 5.45M | 586.00K | 8.00K | 260.00K | 273.00K | 332.00K | 361.00K | 146.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.30M | 5.78M | 942.00K | 1.63M | 2.08M | 2.04M | 21.06M | 11.48M | 1.03M | 1.09M | 538.00K | 557.00K | 496.00K | 236.00K | 352.00K | 542.00K | 301.00K | 0.00 | 361.00K | 0.00 | 189.00K | 214.00K | 266.00K | 780.00K | 727.00K | 700.00K | 0.00 | 700.00K | 700.00K | 600.00K | 200.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 15.70M | 14.74M | 11.59M | 10.53M | 10.10M | 9.76M | 9.71M | 8.78M | 7.95M | 6.74M | 5.56M | 5.29M | 5.45M | 5.67M | 5.90M | 5.97M | 4.99M | 4.49M | 4.31M | 4.32M | 3.59M | 2.96M | 2.57M | 2.33M | 2.09M | 2.10M | 1.90M | 1.70M | 1.70M | 1.30M | 600.00K | 200.00K | 0.00 |
| EBITDA | 74.37M | 76.09M | 85.73M | 77.68M | 83.08M | 72.01M | 64.53M | 58.41M | 55.33M | 52.53M | 44.34M | 43.10M | 46.83M | 39.44M | 34.16M | 30.10M | 25.02M | 23.09M | 24.84M | 20.83M | 20.59M | 21.83M | 19.51M | 12.72M | 9.36M | 7.60M | 6.70M | 5.30M | 3.30M | -500.00K | -1.30M | -1.00M | -300.00K |
| EBITDA Ratio | 12.30% | 14.95% | 17.85% | 18.11% | 17.24% | 15.46% | 15.58% | 16.38% | 16.70% | 17.22% | 16.79% | 17.10% | 19.76% | 18.67% | 17.05% | 15.90% | 16.50% | 17.08% | 18.01% | 17.37% | 19.50% | 23.04% | 24.11% | 20.11% | 18.74% | 17.73% | 17.27% | 16.46% | 12.05% | -2.91% | -15.48% | -41.67% | -50.00% |
| Operating Income | 69.56M | 56.80M | 76.77M | 52.41M | 67.43M | 60.31M | 54.73M | 49.53M | 47.29M | 45.77M | 38.77M | 37.80M | 35.93M | 33.19M | 28.43M | 23.88M | 20.04M | 18.60M | 18.88M | 15.99M | 17.00M | 18.87M | 16.95M | 10.38M | 7.27M | 5.50M | 4.80M | 3.60M | 1.60M | -1.80M | -1.90M | -1.20M | -300.00K |
| Operating Income Ratio | 11.50% | 10.27% | 15.51% | 12.39% | 13.99% | 13.29% | 13.22% | 13.89% | 14.28% | 15.00% | 14.68% | 15.00% | 15.16% | 15.71% | 14.11% | 12.72% | 13.21% | 13.76% | 14.29% | 13.52% | 16.10% | 19.92% | 20.94% | 16.42% | 14.55% | 12.50% | 12.37% | 11.18% | 6.43% | -10.47% | -22.62% | -50.00% | -50.00% |
| Total Other Income/Expenses | -20.18M | -1.23M | 2.55M | 13.10M | 3.48M | -103.00K | -20.97M | -11.39M | -7.16M | -1.07M | -531.00K | 52.00K | 446.00K | 350.00K | -344.00K | -282.00K | -5.76M | -5.35M | -5.61M | -366.00K | -5.16M | -5.06M | -5.45M | -4.25M | -3.30M | -2.80M | -2.30M | -1.90M | 300.00K | 0.00 | 0.00 | 0.00 | 300.00K |
| Income Before Tax | 49.38M | 55.57M | 73.20M | 65.51M | 70.91M | 60.21M | 33.76M | 38.15M | 46.34M | 44.70M | 38.24M | 37.25M | 40.88M | 33.54M | 28.08M | 16.51M | 14.28M | 13.25M | 14.30M | 10.78M | 11.78M | 13.72M | 11.50M | 6.14M | 3.96M | 2.70M | 2.50M | 1.70M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 8.16% | 10.05% | 14.79% | 15.49% | 14.71% | 13.26% | 8.15% | 10.70% | 13.99% | 14.65% | 14.48% | 14.78% | 17.25% | 15.88% | 13.94% | 8.80% | 9.41% | 9.80% | 10.82% | 9.11% | 11.16% | 14.49% | 14.21% | 9.71% | 7.93% | 6.14% | 6.44% | 5.28% | 7.63% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 12.16M | 12.16M | 15.27M | 13.02M | 13.65M | 11.37M | 6.03M | 11.88M | 14.65M | 14.27M | 12.24M | 11.03M | 11.10M | 8.84M | 8.11M | 6.51M | 5.47M | 5.06M | 5.51M | 4.10M | 4.45M | 5.24M | 4.43M | 2.40M | 1.57M | 1.10M | 100.00K | 100.00K | 900.00K | 1.00M | 300.00K | 0.00 | 200.00K |
| Net Income | 14.67M | 43.41M | 57.92M | 52.49M | 57.26M | 10.10M | 22.26M | 20.55M | 22.28M | 19.77M | 12.72M | 17.93M | 20.97M | 15.65M | 11.77M | 10.00M | 8.89M | 6.30M | 8.79M | 6.68M | 7.33M | 8.49M | 7.07M | 3.74M | 2.39M | 1.60M | 2.40M | 1.60M | 700.00K | -2.80M | -2.20M | -1.20M | -200.00K |
| Net Income Ratio | 2.43% | 7.85% | 11.70% | 12.41% | 11.88% | 2.23% | 5.38% | 5.76% | 6.72% | 6.48% | 4.82% | 7.11% | 8.85% | 7.41% | 5.84% | 5.33% | 5.86% | 4.66% | 6.65% | 5.64% | 6.94% | 8.96% | 8.74% | 5.91% | 4.79% | 3.64% | 6.19% | 4.97% | 2.81% | -16.28% | -26.19% | -50.00% | -33.33% |
| EPS | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.52 | 1.78 | 1.34 | 1.01 | 0.84 | 0.75 | 0.54 | 0.74 | 0.56 | 0.66 | 0.77 | 0.70 | 0.13 | 0.12 | 0.05 | 0.08 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| EPS Diluted | 1.28 | 3.34 | 4.49 | 4.09 | 4.49 | 0.80 | 1.76 | 1.64 | 1.77 | 1.62 | 1.05 | 1.51 | 1.75 | 1.32 | 1.00 | 0.83 | 0.75 | 0.54 | 0.73 | 0.54 | 0.61 | 0.67 | 0.55 | 0.11 | 0.11 | 0.05 | 0.07 | 0.05 | 0.02 | -0.27 | -0.22 | -0.12 | -0.02 |
| Weighted Avg Shares Out | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.06M | 11.80M | 11.81M | 11.64M | 11.70M | 11.91M | 11.64M | 11.69M | 11.92M | 11.93M | 11.11M | 11.02M | 10.10M | 9.56M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
| Weighted Avg Shares Out (Dil) | 14.19M | 12.99M | 12.90M | 12.84M | 12.76M | 12.67M | 12.57M | 12.50M | 12.39M | 12.22M | 12.08M | 11.90M | 11.98M | 11.87M | 11.81M | 12.06M | 11.72M | 11.69M | 12.04M | 12.37M | 12.02M | 12.67M | 12.86M | 10.70M | 9.85M | 10.83M | 10.84M | 10.55M | 10.55M | 10.53M | 10.01M | 10.01M | 8.18M |
U.S. Physical Therapy Announces Pricing of $150 Million Underwritten Public Offering of Common Stock
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH) (“U.S. Physical Therapy” or the “Company”) today announced that it has priced an underwritten public offering of 1,666,667 shares of common stock at a price to the public of $90.00 per share of...
U.S. Physical Therapy Announces $150 Million Underwritten Public Offering of Common Stock
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH) (“U.S. Physical Therapy” or the “Company”) today announced that it has commenced an underwritten public offering of $150,000,000 of shares of common stock. The Company has granted the underwriters an option to purchase...
U.S. Physical Therapy Announces $150 Million Underwritten Public Offering of Common Stock
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH) (“U.S. Physical Therapy” or the “Company”) today announced that it has commenced an underwritten public offering of $150,000,000 of shares of common stock. The Company has granted the underwriters an option to purchase...
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
U.S. Physical Therapy Elects Nancy Ham to the Board of Directors
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced today that Ms. Nancy Ham was elected to serve on the Company's Board...
U.S. Physical Therapy, Inc. (USPH) Q1 2023 Earnings Call Transcript
U.S. Physical Therapy, Inc. (NYSE:USPH ) Q1 2023 Earnings Conference Call May 4, 2023 10:30 AM ET Company Participants Chris Reading - President and Chief Executive Officer Jake Martinez - Senior Vice President, Finance and Controller Carey Hendrickson - Chief...
U.S. Physical Therapy Reports First Quarter 2023 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, today reported results for the three months ended March 31, 2023 (“2023 First...
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for undervalued stocks?
U.S. Physical Therapy, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2023 on Wednesday,...
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two companies is the best option for those looking for...
Source: https://incomestatements.info
Category: Stock Reports